Skip to Main Content

"Kimberly has represented our company for a number of years, streamlining defense. After taking the matter over from another law firm, she kept us up to date on what was going on and kept costs contained. Kimberly is the best attorney that I have worked with."

Bud Krohn, Former President, Automotive Consumer Lending Company

Overview

As a former life sciences researcher, Kimberly utilizes her ability to understand and explain complex topics to advise clients as to regulatory and legal liability issues. With a focus on litigation and discovery, she manages the discovery program for complex product liability and toxic tort cases as national counsel.

Kimberly works with the firm’s innovative and award-winning Asbestos Litigation team in helping clients manage their risk profiles and in defending large national dockets. Businesses, academic and medical research centers, premises owners, contractors, and manufacturers are among those who rely on Kimberly’s broad range of litigation and regulatory experience. As national coordinating counsel, she coordinates the discovery for thousands of cases—drafting, responding to and preparing discovery and trial support documents for complex cases throughout the nation.

Kimberly has advised clients in matters of product liability, environmental matters, and legal matters regarding Schedule I controlled substances that involve laws such as the Controlled Substances Act, healthcare and research study regulations under the California Business & Professions Code, requirements relating to DEA licensing and registration of controlled substances, CERCLA/Superfund, RCRA, California Proposition 65, and other alleged solid and liquid hazardous waste violations in response to federal and state agency inspections.

Kimberly is the co-founder and co-lead of the firm’s Psychedelic and Emerging Therapies practice group. Kimberly’s background in biotech startups as a research scientist gives her a unique perspective in emerging areas of law such as psychedelic therapeutics. Psychedelics have garnered headline news as breakthrough medicines for the treatment of psychiatric conditions, including PTSD and major depression. Kimberly keeps current on the academic and commercial research and drug discovery efforts in this rapidly developing field so as to assist clients in navigating and complying with complex regulatory issues and protecting and commercializing intellectual property.

Knowledgeable and energetic, Kimberly is known for identifying key strategies in challenging cases, then easily communicating those ideas to clients and legal teams in order to move forward with the best solutions.

Prior to her admission into the state bar, Kimberly externed with the California Attorney General's Office.

"Kimberly has represented our company for a number of years, streamlining defense. After taking the matter over from another law firm, she kept us up to date on what was going on and kept costs contained. Kimberly is the best attorney that I have worked with."

Bud Krohn, Former President, Automotive Consumer Lending Company


Industries

Services

Education

  • J.D., Golden Gate University
    • Top 10%
    • CALI Award, professional responsibility
    • Moot Court Board
    • Environmental Law Moot Court Board
    • Asian-Pacific Law Association
    • Witkin award for Real Property, highest grade in course
  • B.S., University of California, Davis
    • Biological Sciences
    • Laboratory research assistant – asbestos fiber imaging in lung tissue

Admissions

  • California
  • U.S. District Court, Central District of California
  • U.S. District Court, Northern District of California

Professional Memberships and Certifications

  • American Health Law Association
  • State Bar of California, 2007-present; Environmental Legislation Committee, 2008-2015; Litigation Section, 2018-present
  • Defense Research Institute, 2021-present
  • Alameda County Bar Association, 2008-2015; Executive Committee of the Environmental Section, 2010-2015
  • Psychedelic Bar Association


*Contact Kim to set up an in-person consultation by appointment in the Oakland office.
Experience
  • Advised business in advance of a planned product launch in the United States as to compliance and liability issues with federal and state controlled substance laws and product liability issues.
  • Advised entities on federal regulations and California law governing who is able to prescribe, administer and dispense controlled substances under California law, information needed for DEA licensing requirements, and clinic licensing requirements for human studies involving psychedelic substances.
  • Serves as national coordinating counsel for asbestos client, managing the discovery program.
  • Audited client facilities and operations and update environmental management programs to ensure compliance with applicable environmental health and safety regulations.
  • Negotiated reduced settlements in regulatory enforcement actions.
  • Represented family dry cleaning business in federal and California Department of Toxic Control Substances (DTSC) allegations of groundwater contamination and related cleanup costs. Argued for equitable allocation in consideration of nearby fuel retailer with underground storage tanks.
  • Represented manufacturer when DTSC inspections identified alleged environmental violations related to electroplating process; remedies included training and hazardous waste storage policy upgrades.
  • Represented component part manufacturer when DTSC inspection revealed alleged violations including chemical processing, hazardous waste storage and recordkeeping. Remedies included policy and training upgrades.
  • Counseled manufacturer and retail clients on regulatory compliance issues and in defense of lawsuits involving California's Proposition 65, which requires warnings to Californians about significant exposures to chemicals that allegedly cause cancer, birth defects or other reproductive harm.
  • Advised out-of-state trucking company regarding diesel emissions in an enforcement action brought by the California Air Resources Board.
News Releases | March 15, 2022
Husch Blackwell Launches Psychedelics and Emerging Therapies Practice Group

Husch Blackwell is pleased to announce the formalization of its Psychedelics and Emerging Therapies practice group, making it the first Am Law 100 firm to establish such a practice.

News Releases | April 01, 2021
Husch Blackwell Expands California Footprint
Outside the Office

Kimberly is a proud mother of twins and a group fitness enthusiast, having once been certified by the Aerobics and Fitness Association of America for cardio dance formats. She’s also an avid gardener, with a backyard greenhouse, and enjoys reading horticulture books and magazines.

Psychedelic Therapeutics

Kimberly Chew follows the research and development of these medicines for psychiatric conditions such as PTSD and treatment-resistant depression.

While psychedelic drugs such as MDMA, psilocybin, LSD and DMT are currently federally illegal Schedule 1 substances, the FDA is currently overseeing Phase I, II and III studies exploring the potential therapeutic benefit of these drugs. Members of the Husch Blackwell psychedelic law team are closely following this progress and concurrent proposed state legislation in multiple jurisdictions, and are positioned to help clients navigate what will no doubt be highly complex and novel legal issues.

Stay updated.

Subscribe to receive Husch Blackwell’s news and insights.

Select your preferences